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Reduced litter size in AM+/– matings. The average number of viable 
offspring at postnatal day 21 and the average number of embryos at 
gestational day E14.5 were determined for wild-type matings (white 
bars) and AM+/– intercrosses (gray bars). The actual average number 
is recorded at the top of each bar, while the number at the bottom 
of the bar represents the number of litters examined for each cross. 
*P < 0.01 compared with wild-type crosses.
Figure 2
Reduced litter size correlates with maternal AM+/– genotype. Reciprocal 
heterozygote × wild-type matings were established, and the number of 
viable offspring at postnatal day 21 and the average number of embryos 
at gestational day 14.5 were determined. The gray bars represent wild-
type males crossed with AM+/– females and the white bars represent 
wild-type females crossed with AM+/– males. The actual average num-
ber for each cross is recorded at the top of each bar, while the number 
at the bottom of the bar represents the number of litters examined for 
each cross. *P < 0.01, ‡P < 0.05 compared with the reciprocal cross; 
†P < 0.01 compared with wild-type crosses (Figure 1).
research article































Abnormal implantation spacing in AM+/– females. (A) Timed natural 
matings or blastocyst transfers were performed in wild-type (white bars) 
and AM+/– female mice (gray bars). The number of implanted embryos 
was determined between gestational stages E5.5 and E8.5. The num-
ber at the bottom of the bars represents the number of litters examined 
for each cross. (B) Evans blue dye injections of pregnant wild-type and 
AM+/– female mice at gestational stages E4.5 and E5.5 revealed com-
parable conceptus sizes, demonstrating that timing of implantation was 
conserved in AM+/– female mice. However, AM+/– female mice displayed 
abnormal spacing of and overcrowded conceptuses in the uterine horn 
(arrowheads) compared with wild-type control females.
Figure 4
FGR and developmental defects correlate with placentation and 
fetal AM genotype. (A) Timed matings were established for wild-type 
(white bar) and AM+/– crosses (dark gray bar), and viable embryos 
were counted for gestational stages E9.5–E12.5. Severely growth 
restricted or resorbed embryos were included in the total litter size 
and are represented by the light gray area of the bars. *P < 0.001, 
viable embryos from AM+/– intercrosses compared with viable embry-
os from wild-type crosses at the same gestational stage. (B) Rep-
resentative E9.5 litter from AM+/– intercross. The genotype of each 
embryo is indicated below. Note that growth restriction occurred in 
AM+/– and AM+/+ embryos. (C) Severe growth restriction and failure 
of neural tube closure in an AM+/– embryo (right) compared with an 
AM+/+ littermate (left) isolated at E9.5. (D) Moderate growth restriction 
and severe heart malformations in an AM–/– embryo (right) compared 
with an AM+/+ littermate (left) isolated at E9.5. (E) Expected outcomes 
and actual outcomes for genotypes of growth-restricted or abnormal 
embryos expressed as a percentage of total affected embryos. The 
smaller pie charts only include AM+/– and AM+/+ affected embryos. 
Data are representative of 35 AM+/– litters examined at E9.5, which 
included 97 growth-restricted or malformed embryos.
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High incidence of morphological placental defects in AM+/– intercrosses at E9.5. (A) Saggital image of WT placental/decidual unit from E9.5 
wild-type cross. Embryo and fetal membranes were removed. (B) H&E section of the sample in A, revealing fetal placental and maternal 
decidual tissues. (C) Normal histology of placental layers and maternal-fetal interface. (D) Saggital image of 2 placental/decidual units from E9.5 
AM+/– intercross. Note the juxtaposition of implantations, with fusion of decidua and smaller size of right placental/decidual unit. The right embryo 
was growth restricted. (E) H&E section of another conjoined placenta unit embedded in the same juxtaposed manner as in uterus. The right 
sample has detached maternal-fetal interface, with invasion of the ectopic placenta from the left embryo. (F) Abnormal invasion of TGCs (arrows), 
small labyrinth layer, significantly reduced spongiotrophoblast layer, and almost no maternal-fetal interface are present. (G) Saggital image of 
placental/decidual unit with ectopic placenta that has overgrown the decidual tissue. (H and I) H&E sections through distal pole of the sample in 
G. Note the absence of placental layers and maternal-fetal interface and the presence of edema. (J) Rostral image of twinned placental/decidual 
unit from E9.5 AM+/– intercross. Note 2 fetal membranes within 1 decidua. Neither embryo appeared growth restricted. (K) H&E section through 
another twinned conceptus unit. Note shared decidua, 2 placentas, pool of maternal blood, and growth-restricted embryo. Genotypes were not 
determined. (L) Maternal-fetal interface of the sample in K. Arrows show 2 populations of TGCs invading at the same place. Pl, placenta; D, 
decidua; Lb, labyrinth; Sp, spongiotrophoblast. Arrows show TGCs. Scale bars: 1 mm (B, E, H, and K); 250 μm (C, F, I, and L).
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Fetal AM gene expression is upregulated in invasive TGCs. (A) Fluo-
rescence microscopy of preimplanting blastocysts generated from an 
AM+/– intercross and flushed from the uterine horn of an AM+/– female 
at E3.5. Note the strong fluorescence present in both mural and polar 
trophectoderm cells and a fainter signal in the inner cell mass. The 
left blastocyst is AM–/– and has approximately twice the intensity of 
fluorescence as the right AM+/– blastocyst. (B) Confirmation of TGC 
differentiation in a TS cell line using Hand1 and proliferin gene expres-
sion markers. Results from the quantitative RT-PCR experiment show 
the fold change in gene expression in differentiated TGCs compared 
with that in the undifferentiated TS cell culture, which was arbitrarily 
set at 1. (C) Quantitative measurement of AM gene expression in 
differentiated TGCs compared with that in the undifferentiated TS 
cell culture. All data were normalized to a GAPDH internal control. 
**P < 0.001 compared with undifferentiated TS cells.
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Maternal uterine expression of AM is localized to implantation sites. 



































































Maternal uterine expression of AM is localized to implantation sites. (A–E) In situ hybridiza-
tions for AM gene expression in consecutive serial sections of an implantation site isolated 
from a wild-type cross at E5. The schematic diagram depicts the approximate location of the 
series of sections shown in A–E, which were each approximately 150 μm apart. Note the 
gradual increase in maternal uterine AM gene expression that peaked at the center of the 
implantation site in C next to the developing embryo. (F) High-power magnification of the 
implantation site shown in C. Note the presence of the embryo (e) and yolk sac cavity (ys). 
The fetal tissue is surrounded by a thin line of intense, punctuate staining, likely representa-
tive of mural TGCs. Maternal expression of AM can be visualized in the luminal epithelium 
(le) and surrounding stroma (s). H&E staining of wild-type placentas at E9.5 (G) and E14.5 
(I), with corresponding in situ hybridizations of serial sections (H and J, respectively) showing 
robust AM expression in the maternal decidua (MD) compared with weak expression in the 
fetal placenta (FP). m, mesometrium.
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Effects of maternal and fetal depletion of AM in pregnancy. In wild-
type mice (Normal), AM gene expression is highly and coordinately 
upregulated in the maternal uterine luminal epithelium and surrounding 
stroma as well as fetal trophectoderm cells at the time of implantation. 
Due to effective gene targeting of the AM gene, AM peptide secretion 
is reduced by 50% in the uterine wall of heterozygote females. This 
modest genetic reduction results in abnormal implantation spacing, 
morphological defects in placentation, FGR, and subsequent reduced 
fertility. Implanting blastocysts from AM+/– intercrosses can be of 3 
genotypes, AM+/+, AM+/–, or AM–/–, and thus they contribute different 
amounts of AM peptide to the implantation site: 100%, 50%, or 0% of 
normal, respectively. Thus, the combined effects of maternal and fetal 
depletion of AM result in reduced and varying concentrations of AM 
peptide at the implantation site. While heterozygous loss of fetal AM 
does not significantly affect the incidence of FGR, a greater incidence 
of FGR is significantly associated with AM–/– embryos, suggesting an 
essential function for the peptide during early embryonic development. 
ICM, inner cell mass.
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secrete AM into the culture media for 48 hours and subsequently 
reduce their production of AM by 70% as the cells spontaneously 
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